Personalised cancer vaccine expected to be approved next year

A bespoke vaccine that is tailored to target an individual's unique skin cancer reduced rates of recurrence or death in a late-stage trial, making an approval expected

To respect copyright, we link to the source rather than republishing the full text. Read the complete article on New Scientist.